CORRECTION FROM SOURCE: Thiogenesis Therapeutics, Corp. Announces Closing of Qualifying Transaction
A correction from Thiogenesis Therapeutics, Corp. is issued for its news release of April 5, 2022. The news release has been corrected for the number of shares now held by Vincent Stanton, Jr. under the
Patricep Rioux Kostenloser Wertpapierhandel Vincent Stanton Jr Kim Tsuchimoto W Hogan Mullally Christopherm Starr
Source: finanznachrichten.de